2023
DOI: 10.1039/d3bm00239j
|View full text |Cite
|
Sign up to set email alerts
|

Albumin-based near-infrared phototheranostics for frequency upconversion luminescence/photoacoustic dual-modal imaging-guided photothermal therapy

Hui Yu,
Aliya Tiemuer,
Yanyan Zhu
et al.

Abstract: We constructed facile “one-for-all” phototheranostics (NRh-BSA NPs) assembled from an organic molecular dye (NRh) and BSA for frequency upconversion luminescence/photoacoustic (FUCL/PA) dual-modal imaging-guided photothermal therapy (PTT).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Among them, frequency upconversion luminescence (FUCL) has gained prominence in biosensing and imaging due to its superior properties of deep-tissue penetration, low autofluorescence, high photostability, and high signal-to-noise ratio. Furthermore, diverse FUCL-based systems have been extensively developed for detecting metal ions, tumor hypoxia, and cancer therapy 35 , 36 , 37 , 38 , 39 , 40 , 41 . Recently, our group reported the design of 658 nm light-activable upconversion luminescent NO nano-prodrugs that facilitated precise real-time NO monitoring and tumor treatment guided by FUCL imaging 42 .…”
Section: Introductionmentioning
confidence: 99%
“…Among them, frequency upconversion luminescence (FUCL) has gained prominence in biosensing and imaging due to its superior properties of deep-tissue penetration, low autofluorescence, high photostability, and high signal-to-noise ratio. Furthermore, diverse FUCL-based systems have been extensively developed for detecting metal ions, tumor hypoxia, and cancer therapy 35 , 36 , 37 , 38 , 39 , 40 , 41 . Recently, our group reported the design of 658 nm light-activable upconversion luminescent NO nano-prodrugs that facilitated precise real-time NO monitoring and tumor treatment guided by FUCL imaging 42 .…”
Section: Introductionmentioning
confidence: 99%